428 related articles for article (PubMed ID: 2856398)
1. Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3',5'-cyclic adenosine monophosphate, and glucocorticoids.
Gagner JP; Drouin J
Mol Endocrinol; 1987 Oct; 1(10):677-82. PubMed ID: 2856398
[TBL] [Abstract][Full Text] [Related]
2. Complex transcriptional regulation by glucocorticoids and corticotropin-releasing hormone of proopiomelanocortin gene expression in rat pituitary cultures.
Eberwine JH; Jonassen JA; Evinger MJ; Roberts JL
DNA; 1987 Oct; 6(5):483-92. PubMed ID: 3500023
[TBL] [Abstract][Full Text] [Related]
3. Opposite regulation of pro-opiomelanocortin gene transcription by glucocorticoids and CRH.
Gagner JP; Drouin J
Mol Cell Endocrinol; 1985 Apr; 40(1):25-32. PubMed ID: 3873366
[TBL] [Abstract][Full Text] [Related]
4. Modulation of basal and corticotropin-releasing factor-stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary.
Levin N; Blum M; Roberts JL
Endocrinology; 1989 Dec; 125(6):2957-66. PubMed ID: 2555132
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor differentially regulates anterior and intermediate pituitary lobe proopiomelanocortin gene transcription, nuclear precursor RNA and mature mRNA in vivo.
Autelitano DJ; Blum M; Lopingco M; Allen RG; Roberts JL
Neuroendocrinology; 1990 Feb; 51(2):123-30. PubMed ID: 2154714
[TBL] [Abstract][Full Text] [Related]
6. Developmental regulation of proopiomelanocortin gene expression in the fetal and neonatal rat pituitary.
Scott RE; Pintar JE
Mol Endocrinol; 1993 Apr; 7(4):585-96. PubMed ID: 8502239
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing hormone or dexamethasone regulates rat proopiomelanocortin transcription through Tpit/Pitx-responsive element in its promoter.
Murakami I; Takeuchi S; Kudo T; Sutou S; Takahashi S
J Endocrinol; 2007 May; 193(2):279-90. PubMed ID: 17470519
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the expression and secretion of urocortin 2 in rat pituitary.
Nemoto T; Iwasaki-Sekino A; Yamauchi N; Shibasaki T
J Endocrinol; 2007 Feb; 192(2):443-52. PubMed ID: 17283244
[TBL] [Abstract][Full Text] [Related]
9. Dopamine inhibition of proopiomelanocortin gene expression in the intermediate lobe of the pituitary. Interactions with corticotropin-releasing factor and the beta-adrenergic receptors and the adenylate cyclase system.
Loeffler JP; Demeneix BA; Kley NA; Höllt V
Neuroendocrinology; 1988 Feb; 47(2):95-101. PubMed ID: 2963967
[TBL] [Abstract][Full Text] [Related]
10. Regulation of proopiomelanocortin gene transcription during single and repeated immobilization stress.
Noguchi T; Makino S; Maruyama H; Hashimoto K
Neuroendocrinology; 2006; 84(1):21-30. PubMed ID: 17085933
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of serum- and glucocorticoid-regulated kinase-1 and glucocorticoids on POMC transcription and ACTH release.
Reiter MH; Vila G; Knosp E; Baumgartner-Parzer SM; Wagner L; Stalla GK; Luger A
Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E336-41. PubMed ID: 21586695
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides.
Margioris AN; Grino M; Protos P; Gold PW; Chrousos GP
J Clin Endocrinol Metab; 1988 May; 66(5):922-6. PubMed ID: 2834412
[TBL] [Abstract][Full Text] [Related]
13. Release of melanotroph- and corticotroph-type proopiomelanocortin derivatives into blood after administration of corticotropin-releasing hormone in patients with septic shock without adrenocortical insufficiency.
Matejec R; Löcke G; Mühling J; Harbach HW; Langefeld TW; Bödeker RH; Hempelmann G
Shock; 2009 Jun; 31(6):553-60. PubMed ID: 18827746
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin-releasing hormone stimulates proopiomelanocortin transcription by cFos-dependent and -independent pathways: characterization of an AP1 site in exon 1.
Boutillier AL; Monnier D; Lorang D; Lundblad JR; Roberts JL; Loeffler JP
Mol Endocrinol; 1995 Jun; 9(6):745-55. PubMed ID: 8592520
[TBL] [Abstract][Full Text] [Related]
15. Ontogeny of basal and regulated proopiomelanocortin-derived peptide secretion from fetal and neonatal pituitary intermediate lobe cells: melanotrophs exhibit transient glucocorticoid responses during development.
Lugo DI; Pintar JE
Dev Biol; 1996 Jan; 173(1):110-8. PubMed ID: 8575613
[TBL] [Abstract][Full Text] [Related]
16. Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone.
Parsadaniantz SM; Batsché E; Gegout-Pottie P; Terlain B; Gillet P; Netter P; Kerdelhué B
Neuroendocrinology; 1997 Jan; 65(1):53-63. PubMed ID: 9032774
[TBL] [Abstract][Full Text] [Related]
17. Activation of protein kinase C differentially regulates corticotropin-releasing factor-stimulated peptide secretion and cyclic AMP formation of intermediate and anterior pituitary cells in culture.
Lutz-Bucher B; Félix JM; Koch B
Peptides; 1990; 11(6):1183-9. PubMed ID: 1965031
[TBL] [Abstract][Full Text] [Related]
18. Pro-opiomelanocortin gene: a model for negative regulation of transcription by glucocorticoids.
Drouin J; Charron J; Gagner JP; Jeannotte L; Nemer M; Plante RK; Wrange O
J Cell Biochem; 1987 Dec; 35(4):293-304. PubMed ID: 3326882
[TBL] [Abstract][Full Text] [Related]
19. Ontogeny of basal and regulated secretion from POMC cells of the developing anterior lobe of the rat pituitary gland.
Lugo DI; Pintar JE
Dev Biol; 1996 Jan; 173(1):95-109. PubMed ID: 8575641
[TBL] [Abstract][Full Text] [Related]
20. Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor.
Latchoumanin O; Mynard V; Devin-Leclerc J; Dugué MA; Bertagna X; Catelli MG
Endocrinology; 2007 Jan; 148(1):422-32. PubMed ID: 17038560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
